Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Huashi Pharmaceutical is a specialized pharmaceutical company based in China and a key subsidiary of Shanghai Pharmaceuticals Holding Co., Ltd. (SPH). The company focuses on the research, development, and large-scale manufacturing of high-quality generic drugs and innovative formulations across several therapeutic areas, including cardiovascular, metabolic, and neurological health. Huashi operates multiple GMP-certified production facilities and maintains a significant presence in the domestic Chinese market through its integration with SPH's extensive distribution and retail networks. Its business model combines traditional pharmaceutical manufacturing with high-tech R&D to improve drug delivery systems and patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Huashi Pharmaceutical.